Name | (+)-syringaresinol |
---|---|
Synonyms |
syringaresinol
(+)-(7S,7'S,8R,8'R)-4,4'-dihydroxy-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane 4,4'-(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxyphenol) Phenol, 4,4'-[(1S,3aR,4S,6aR)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2,6-dimethoxy- (-) Syringaresinol (+)-lirioresinol B (+/-)-syringaresinol 4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2,6-dimethoxyphenyl] |
Description | (+)-Syringaresinol, a lignan, is a NFAT transcription factor inhibitor, with an IC50 of 329.4 μM. (+)-Syringaresinol also can be used for the research of lymphocytic leukemia[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 329.4 μM (NFAT transcription factor)[1] |
In Vitro | (+)-Syringaresinol inhibits the growth of P-388 cells, with an ED50 0.41 μg/mL[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 594.7±50.0 °C at 760 mmHg |
Molecular Formula | C22H26O8 |
Molecular Weight | 418.437 |
Flash Point | 313.5±30.1 °C |
Exact Mass | 418.162781 |
PSA | 95.84000 |
LogP | 0.71 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.578 |